SCHEMBL7921652

SCHEMBL7921652

CS(=O)(=O)C(=O)Nc1cccc2c1CC1(CC2)COC(N)=N1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.57
ADRA2A P08913 1/20 0.57
ALDH1A1 P00352 5/20 0.35
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
LMNA P02545 1/20 0.34
THRA P10827 1/20 0.34
THRB P10828 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
KDM4E B2RXH2 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C19 P33261 2/20 0.34
CYP2D6 P10635 1/20 0.34
TSHR P16473 2/20 0.33
BACE1 P56817 2/20 0.32
MAPT P10636 1/20 0.32
CYP2C9 P11712 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7921654 0.89 TAAR1 (0.54) TAAR1ADRA2AALDH1A1MEN1KMT2A
SCHEMBL7910877 0.87 ADRA2A (0.62) TAAR1ADRA2AALDH1A1MEN1KMT2A
SCHEMBL7918622 0.85 ADRA2A (0.60) TAAR1ADRA2AALDH1A1MEN1KMT2A
SCHEMBL7913278 0.85 ADRA2A (0.60) TAAR1ADRA2AALDH1A1MEN1KMT2A
SCHEMBL7924900 0.82 TAAR1 (0.55) TAAR1ADRA2AALDH1A1MEN1KMT2A
SCHEMBL7923351 0.81 ADRA2A (0.60) TAAR1ADRA2A
SCHEMBL7911111 0.78 TAAR1 (0.65) TAAR1ADRA2ABACE1
SCHEMBL7918363 0.77 TAAR1 (0.51) TAAR1ADRA2AALDH1A1MEN1KMT2A
SCHEMBL7919840 0.77 TAAR1 (0.51) TAAR1ADRA2AALDH1A1MEN1KMT2A
SCHEMBL7918614 0.77 TAAR1 (0.51) TAAR1ADRA2AALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010042475-A1 SPIROAMINOOXAZOLINE ANALOGUES AS ALPHA2C ADRENERGIC RECEPTOR MODULATORS SCHERING CORPORATION (US) 2010-04-15 WO disclosed